- Home
- KPLT vs SER Comparison
KPLT vs SER Comparison
Compare KPLT & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPLT | SER |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.9M | 29.3M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | KPLT | SER |
|---|---|---|
| Price | $6.77 | $3.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $10.00 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 68.7K | 63.5K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $280,839,000.00 | $116,000.00 |
| Revenue This Year | $21.42 | $134.46 |
| Revenue Next Year | $15.48 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.15 | N/A |
| 52 Week Low | $5.50 | $1.71 |
| 52 Week High | $24.34 | $7.92 |
Technical Indicators
Market Signals| Indicator | KPLT | SER |
|---|---|---|
| Relative Strength Index (RSI) | 51.77 | 58.76 |
| Support Level | $6.67 | $2.22 |
| Resistance Level | $7.03 | $2.86 |
| Average True Range (ATR) | 0.40 | 0.32 |
| MACD | 0.08 | 0.13 |
| Stochastic Oscillator | 55.47 | 91.27 |
Price Performance
Historical ComparisonAbout KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.